This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

• Narrativer Inhalt
• XML
• JSON

: MTBChemo1MedicationStatement4

Raw xml | Download

<MedicationStatement xmlns="http://hl7.org/fhir">
  <id value="MTBChemo1MedicationStatement4"/>
  <meta>
    <profile
             value="https://www.medizininformatik-initiative.de/fhir/core/modul-medikation/StructureDefinition/MedicationStatement"/>
  </meta>
  <language value="de"/>
  <text>
    <status value="generated"/>
    <div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: MedicationStatement MTBChemo1MedicationStatement4</b></p><a name="de-MTBChemo1MedicationStatement4"> </a><a name="de-hcMTBChemo1MedicationStatement4"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="https://medizininformatik-initiative.github.io/kerndatensatzmodul-medikation/2027.0.0-ballot/StructureDefinition-mii-pr-medikation-medication-statement.html">MII PR Medikation MedicationStatement</a></p></div><p><b>partOf</b>: <a href="Procedure-MTBChemo1Procedure.html">Procedure Chemotherapy</a></p><p><b>status</b>: Completed</p><p><b>medication</b>: <span title="Codes:">Z4 Carboplatin AUC5 d1, pegliposomales Doxorubicin 30 mg/m2, d1</span></p><p><b>subject</b>: <a href="Patient-PatientKimMusterperson.html">Kim Musterperson  (no stated gender), DoB: 1956-03-14</a></p><p><b>effective</b>: 2023-03-29</p></div>
  </text>
  <partOf>🔗 
    <reference value="Procedure/MTBChemo1Procedure"/>
  </partOf>
  <status value="completed"/>
  <medicationCodeableConcept>
    <text
          value="Z4 Carboplatin AUC5 d1, pegliposomales Doxorubicin 30 mg/m2, d1"/>
  </medicationCodeableConcept>
  <subject>🔗 
    <reference value="Patient/PatientKimMusterperson"/>
  </subject>
  <effectiveDateTime value="2023-03-29"/>
</MedicationStatement>